Trident Lifeline Ltd — Updates, 17-04-2025: Company Update

Trident Lifeline Limited has announced a board meeting on further allotment in its subsidiary, TNS Pharma Private Limited, involving the acquisition of 10.20 lakh equity shares. The total ownership in TNS Pharma remains stable at 51%. This strategic move reflects the company’s commitment to strengthening its subsidiary while maintaining control. Investors may view this as a positive outlook, indicating sustained investment in growth opportunities within the pharmaceutical sector, despite no change in shareholding percentage.